Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 48154 [2019-19776]

Download as PDF 48154 Federal Register / Vol. 84, No. 177 / Thursday, September 12, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting. Information about CHAC can be found on the CHAC website at https:// www.cdc.gov/maso/facm/ facmCHACHSPT.html. Meeting information and the agenda can be found at https://www.chachspt.com. DATES: November 13, 2019, 8:30 a.m.– 5:00 p.m. Eastern Time (ET) and November 14, 2019, 8:30 a.m.–3:00 p.m. Eastern Time (ET). ADDRESSES: This meeting will be held in-person and by webinar. The address for the meeting is 5600 Fishers Lane, Rockville, Maryland 20857. While this meeting is open to the public, advance registration is required to attend inperson. Please visit the meeting information website to register: https:// www.chachspt.com. The deadline for online registration is 12:00 p.m. ET on November 6, 2019. To access the meeting virtually, please use the information below. Registration is encouraged, but not required, for virtual attendance. • Webinar link: https:// hrsa.connectsolutions.com/fall-2019chac-meeting/ • Conference call-in number: 888–469– 0878 Passcode: 8802805 FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Senior Public Health Advisor, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 20857; 301–443–5807; or CHACAdvisoryComm@hrsa.gov. SUPPLEMENTARY INFORMATION: CHAC was established under Section 222 of the Public Health Service Act, [42 U.S.C. Section 217a], as amended. The purpose of CHAC is to advise the Secretary, HHS; the Director, CDC; and the Administrator, HRSA regarding objectives, strategies, policies, and priorities for HIV, viral hepatitis, and other STDs; prevention and treatment jbell on DSK3GLQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:27 Sep 11, 2019 Jkt 247001 efforts including surveillance of HIV infection, viral hepatitis, and other STDs, and related behaviors; epidemiologic, behavioral, health services, and laboratory research on HIV, viral hepatitis, and other STDs; identification of policy issues related to HIV/viral hepatitis/STD professional eduction, patient healthcare delivery, and prevention services; Agency policies about prevention of HIV, viral hepatitis and other STDs; treatment, healthcare delivery, and research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions of providing prevention and treatment services; programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the Agencies in their developoment of responses to emerging health needs related to HIV, viral hepatitis, and other STDs. During the November 13–14, 2019 meeting, CHAC will discuss issues related to the President’s initiative on ‘‘Ending the HIV Epidemic: A Plan for America,’’ building community capacity, strategies for engaging people with HIV who are out of care, models of clinical care, workforce issues, preexposure prophylaxis services in community health centers, and pending committee reports. Agenda items are subject to change as priorities dictate. Refer to the CHAC meeting information website for any updated information concerning the meeting. Members of the public will have the opportunity to provide comments. Requests to offer oral comments will be accepted in the order they are received and may be limited as time allows. Public participants may also submit written statements as further described below. To submit written comments or to request time for an oral comment at the meeting, please register online by 12:00 p.m. ET on November 6, 2019. For additional details, visit the meeting information website at https:// www.chachspt.com. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Theresa Jumento at the address and phone number listed above at least 10 business days prior to the meeting. Since this meeting occurs in a federal government building, attendees must go through a security check to enter the building. Non-U.S. Citizen attendees must notify HRSA of their planned attendance at least 20 business days prior to the meeting in order to facilitate their entry into the building. All attendees are PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 required to present government-issued identification prior to entry. Maria G. Button, Director, Division of the Executive Secretariat. [FR Doc. 2019–19776 Filed 9–11–19; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of The Director, National Institutes of Health; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Advisory Committee on Research on Women’s Health, October 23, 2019, 09:00 a.m. to October 23, 2019, 04:30 p.m., National Institutes of Health, Natcher Building, Conference Room E1/E2, 45 Center Drive, Bethesda, MD 20892 which was published in the Federal Register on February 08, 2019, 84 FR 2895. The meeting notice is amended to update the agenda description to include a discussion on the development of a challenge prize for enhancing faculty gender equity and diversity in biomedical sciences. The discussion will include the following topics: Clarifying the goal and fit with a prize model; defining measures of institutional faculty gender equity and diversity; framing challenge description for a broad applicant pool; judging criteria; and identifying barriers. The meeting is open to the public. Dated: September 6, 2019. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–19692 Filed 9–11–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory General Medical Sciences Council. The meeting will be open to the public as indicated below, with a short public comment period at the end. Attendance is limited by the space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other E:\FR\FM\12SEN1.SGM 12SEN1

Agencies

[Federal Register Volume 84, Number 177 (Thursday, September 12, 2019)]
[Notices]
[Page 48154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19776]



[[Page 48154]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC)/HRSA Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment 
(CHAC) has scheduled a public meeting. Information about CHAC can be 
found on the CHAC website at https://www.cdc.gov/maso/facm/facmCHACHSPT.html. Meeting information and the agenda can be found at 
https://www.chachspt.com.

DATES: November 13, 2019, 8:30 a.m.-5:00 p.m. Eastern Time (ET) and 
November 14, 2019, 8:30 a.m.-3:00 p.m. Eastern Time (ET).

ADDRESSES: This meeting will be held in-person and by webinar. The 
address for the meeting is 5600 Fishers Lane, Rockville, Maryland 
20857. While this meeting is open to the public, advance registration 
is required to attend in-person. Please visit the meeting information 
website to register: https://www.chachspt.com. The deadline for online 
registration is 12:00 p.m. ET on November 6, 2019. To access the 
meeting virtually, please use the information below. Registration is 
encouraged, but not required, for virtual attendance.

 Webinar link: https://hrsa.connectsolutions.com/fall-2019-chac-meeting/
 Conference call-in number: 888-469-0878 Passcode: 8802805

FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Senior Public Health 
Advisor, HIV/AIDS Bureau, HRSA, 5600 Fishers Lane, Rockville, Maryland 
20857; 301-443-5807; or [email protected].

SUPPLEMENTARY INFORMATION: CHAC was established under Section 222 of 
the Public Health Service Act, [42 U.S.C. Section 217a], as amended.
    The purpose of CHAC is to advise the Secretary, HHS; the Director, 
CDC; and the Administrator, HRSA regarding objectives, strategies, 
policies, and priorities for HIV, viral hepatitis, and other STDs; 
prevention and treatment efforts including surveillance of HIV 
infection, viral hepatitis, and other STDs, and related behaviors; 
epidemiologic, behavioral, health services, and laboratory research on 
HIV, viral hepatitis, and other STDs; identification of policy issues 
related to HIV/viral hepatitis/STD professional eduction, patient 
healthcare delivery, and prevention services; Agency policies about 
prevention of HIV, viral hepatitis and other STDs; treatment, 
healthcare delivery, and research and training; strategic issues 
influencing the ability of CDC and HRSA to fulfill their missions of 
providing prevention and treatment services; programmatic efforts to 
prevent and treat HIV, viral hepatitis, and other STDs; and support to 
the Agencies in their developoment of responses to emerging health 
needs related to HIV, viral hepatitis, and other STDs.
    During the November 13-14, 2019 meeting, CHAC will discuss issues 
related to the President's initiative on ``Ending the HIV Epidemic: A 
Plan for America,'' building community capacity, strategies for 
engaging people with HIV who are out of care, models of clinical care, 
workforce issues, pre-exposure prophylaxis services in community health 
centers, and pending committee reports. Agenda items are subject to 
change as priorities dictate. Refer to the CHAC meeting information 
website for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Requests to offer oral comments will be accepted in the order 
they are received and may be limited as time allows. Public 
participants may also submit written statements as further described 
below. To submit written comments or to request time for an oral 
comment at the meeting, please register online by 12:00 p.m. ET on 
November 6, 2019. For additional details, visit the meeting information 
website at https://www.chachspt.com. Individuals who plan to attend and 
need special assistance or another reasonable accommodation should 
notify Theresa Jumento at the address and phone number listed above at 
least 10 business days prior to the meeting. Since this meeting occurs 
in a federal government building, attendees must go through a security 
check to enter the building. Non-U.S. Citizen attendees must notify 
HRSA of their planned attendance at least 20 business days prior to the 
meeting in order to facilitate their entry into the building. All 
attendees are required to present government-issued identification 
prior to entry.

Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-19776 Filed 9-11-19; 8:45 am]
 BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.